Expression of hepatitis C virus core protein inhibits interferon-induced nuclear import of STATs

Journal of Medical Virology

Volumn 73, Issue 4, 2004, Pages 536-547

  Melén, Krister ^a   Fagerlund, Riku ^a   Nyqvist, Maria ^a   Keskinen, Päivi ^a   Julkunen, Ilkka ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Hepatitis C virus; Interferons; Mx proteins; Nuclear import; STAT

Indexed keywords

CORE PROTEIN; GAMMA INTERFERON; INTERFERON; MYXOVIRUS RESISTANCE PROTEIN A; NONSTRUCTURAL PROTEIN 5A; NS3 4A PROTEIN; NS4B PROTEIN; NS5B PROTEIN; RIBAVIRIN; STAT PROTEIN; STAT1 PROTEIN; STAT2 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CELL NUCLEUS; CONTROLLED STUDY; DRUG RESISTANCE; GENE EXPRESSION; GENETIC TRANSFECTION; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; HOST RESISTANCE; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; OSTEOSARCOMA CELL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; VIRUS EXPRESSION;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL LINE, TUMOR; CELL NUCLEUS; DNA-BINDING PROTEINS; GTP-BINDING PROTEINS; HEPACIVIRUS; HUMANS; INTERFERON-ALPHA; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSFECTION; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS;

EID: 3042740355     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20123     Document Type: Article

References (51)

1. Barba G, Harper F, Harada T, Kohara M, Goulinet S, Matsuura Y, Eder G, Schaff Z, Chapman MJ, Miyamura T, Brechot C. 1997. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci USA 94:1200-1205.
2. Bartenschlager R, Lohmann V. 2000. Replication of hepatitis C virus. J Gen Virol 81:1631-1648.
3. Basu A, Meyer K, Ray RB, Ray R. 2001. Hepatitis C virus core protein modulates the interferon-induced transacting factors of Jak/Stat signaling pathway but does not affect the activation of downstream IRF-1 or 561 gene. Virology 288:379-390.
4. Blindenbacher A, Duong FH, Hunziker L, Stutvoet ST, Wang X, Terracciano L, Moradpour D, Blum HE, Alonzi T, Tripodi M, La Monica N, Heim MH. 2003. Expression of hepatitis c virus proteins inhibits interferon α signaling in the liver of transgenic mice. Gastroenterology 124:1465-1475.
5. Bode JG, Ludwig S, Ehrhardt C, Albrecht U, Erhardt A, Schaper F, Heinrich PC, Haussinger D. 2003. IFN-α antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J 17:488-490.
6. Brass V, Bieck E, Montserret R, Wolk B, Hellings JA, Blum HE, Penin F, Moradpour D. 2002. An amino-terminal amphipathic alpha-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A. J Biol Chem 277:8130-8139.
7. Cantell K, Hirvonen S, Kauppinen H-L, Myllylä G. 1981. Production of interferon in human leukocytes from normal donors with the use of Sendai virus. Methods Enzymol 78:29-38.
8. Cantell K, Hirvonen S, Kauppinen H-L. 1986. Production and partial purification of human immune interferon. Methods Enzymol 119:54-63.
9. Cerny A, Chisari FV. 1999. Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence. Hepatology 30:595-601.
10. Chung KM, Lee J, Kim JE, Song OK, Cho S, Lim J, Seedorf M, Hahm B, Jang SK. 2000. Nonstructural protein 5A of hepatitis C virus inhibits the function of karyopherin beta3. J Virol 74:5233-5241.
11. Cooper S, Erickson AL, Adams EJ, Kansopon J, Weiner AJ, Chien DY, Houghton M, Parham P, Walker CM. 1999. Analysis of a successful immune response against hepatitis C virus. Immunity 10:439-449.
12. Fagerlund R, Melén K, Kinnunen L, Julkunen I. 2002. Arginine/lysine-rich nuclear localization signals mediate interactions between dimeric STATs and importin α5. J Biol Chem 277:30072-30078.
13. Foy E, Li K, Wang C, Sumpter R, Jr., Ikeda M, Lemon SM, Gale M, Jr. 2003. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300:1145-1148.
14. Francois C, Duverlie G, Rebouillat D, Khorsi H, Castelain S, Blum HE, Gatignol A, Wychowski C, Moradpour D, Meurs EF. 2000. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis. J Virol 74:5587-5596.
15. Gale M, Jr., Blakely CM, Kwieciszewski B, Tan SL, Dossett M, Tang NM, Korth MJ, Polyak SJ, Gretch DR, Katze MG. 1998. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: Molecular mechanism of kinase regulation. Mol Cell Biol 18:5208-5218.
16. Ghosh S, May MJ, Kopp EB. 1998. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225-260.
17. Grakoui A, McCourt DW, Wychowski C, Feinstone SM, Rice CM. 1993a. A second hepatitis C virus-encoded proteinase. Proe Natl Acad Sci USA 90:10583-10587.
18. Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice CM. 1993b. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 67:1385-1395.
19. Heim MH, Moradpour D, Blum HE. 1999. Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J Virol 73:8469-8475.
20. Hügle T, Fehrmann F, Bieck E, Kohara M, Kräusslich H-G, Rice CM, Blum HE, Moradpour D. 2001. The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein. Virology 264:70-81.
21. Kato N, Yoshida H, Kioko Ono-Nita S, Kato J, Goto T, Otsuka M, Lan K, Matsushima K, Shiratori Y, Omata M. 2000. Activation of intracellular signaling by hepatitis B and C viruses, C-viral core is the most potent signal transducer. Hepatology 32:405-412.
22. Keskinen P, Nyqvist M, Sareneva T, Pirhonen J, Melén K, Julkunen I. 1999. Impaired antiviral response in human hepatoma cells. Virology 263:364-375.
23. Keskinen P, Melén K, Julkunen I. 2002. Expression of HCV structural proteins impairs IFN-mediated antiviral response. Virology 299:164-171.
24. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH. 1990. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 12:671-675.
25. Lehtonen A, Matikainen S, Julkunen I. 1997. Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages. J Immunol 159:794-803.
26. Matsuura Y, Suzuki T, Suzuki R, Sato M, Aizaki H, Saito I, Miyamura T. 1994. Processing of E1 and E2 glycoproteins of hepatitis C virus expressed in mammalian and insect cells. Virology 205:141-150.
27. McLauchlan J. 2000. Properties of the hepatitis C virus core protein: A structural protein that modulates cellular processes. J Viral Hepat 7:2-14.
28. Melén K, Keskinen P, Ronni T, Sareneva T, Lounatmaa K, Julkunen I. 1996. Human MxB protein, an interferon-alpha-inducible GTPase, contains a nuclear targeting signal and is localized in the heterochromatin region beneath the nuclear envelope. J Biol Chem 271:23478-23486.
29. Melén K, Keskinen P, Lehtonen A, Julkunen I. 2000. Interferon-induced gene expression and signaling in human hepatoma cell lines. J Hepatol 33:764-772.
30. Melén K, Kinnunen L, Julkunen I. 2001. Arginine/lycine-rich structural element is involved in IFN-induced nuclear import of STATs. J Biol Chem 276:16447-16455.
31. Moradpour D, Englert C, Wakita T, Wands JR. 1996. Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology 222:51-63.
32. Moradpour D, Kary P, Rice CM, Blum HE. 1998. Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins. Hepatology 28:192-201.
33. Muramutsu S, Ishido S, Fujita T, Itoh M, Hotta H. 1997. Nuclear localisation of the NS3 protein of hepatitis C virus and factors affecting the localization. J Virol 71:4954-4961.
34. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J. 1982. Growth of human hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Res 42:3858-3863.
35. Pawlotsky JM. 2000. Hepatitis C virus resistance to antiviral therapy. Hepatology 32:889-896.
36. Podevin P, Sabile A, Gajardo R, Delhem N, Abadie A, Lozach PY, Beretta L, Brechot C. 2001. Expression of hepatitis C virus NS5A natural mutants in a hepatocytic cell line inhibits the antiviral effect of interferon in a PKR-independent manner. Hepatology 33:1503-1511.
37. Ray RB, Meyer K, Ray R. 1996. Suppression of apoptotic cell death by hepatitis C virus core protein. Virology 226:176-182.
38. Ray RB, Steele R, Meyer K, Ray R. 1997. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J Biol Chem 272:10983-10986.
39. Ray RB, Meyer K, Steele R, Shrivastava A, Aggarwal BB, Ray R. 1998. Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus. J Biol Chem 273:2256-2259.
40. Reed KE, Rice CM. 2000. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 242:55-84.
41. Ronni T, Melén K, Malygin A, Julkunen I. 1993. Control of IFN-inducible MxA gene expression in human cells. J Immunol 150:1715-1726.
42. Ronni T, Matikainen S, Lehtonen A, Palvimo J, Dellis J, Van Eylen F, Goetschy JF, Horisberger M, Content J, Julkunen I. 1998. The proximal interferon-stimulated response elements are essential for interferon responsiveness: Apromoter analysis of the antiviral MxA gene. J Interferon Cytokine Res 18:773-781.
43. Ruggieri A, Harada T, Matsuura Y, Miyamura T. 1997. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology 229:68-76.
44. Schmidt-Mende J, Bieck E, Hügle T, Penin F, Rice CM, Blum HE, Moradpour D. 2001. Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase. J Biol Chem 276:44052-44063.
45. Sekimoto T, Imamoto N, Nakajima K, Hirano T, Yoneda Y. 1997. Extracellular signal-dependent nuclear import of Stat1 is mediated by nuclear pore-targeting complex formation with NPI-1, but notRch1. EMBO J 16:7067-7077.
46. Shih CM, Chen CM, Chen SY, Lee YH. 1995. Modulation of the transsuppression activity of hepatitis C virus core protein by phosphorylation. J Virol 69:1160-1171.
47. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. 1998. How cells respond to interferons. Annu Rev Biochem 67:227-264.
48. Taylor DR, Shi ST, Romano PR, Barber GN, Lai MM. 1999. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285:107-110.
49. Wölk B, Sansonno D, Krausslich HG, Dammacco F, Rice CM, Blum HE, Moradpour D. 2000. Subcellular localization, stability, and transcleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. J Virol 74:2293-2304.
50. Yoshida H, Kato N, Shiratori Y, Otsuka M, Maeda S, Kato J, Omata M. 2001. Hepatitis C virus core protein activates nuclear factor kappa B-dependent signaling through tumor necrosis factor receptor-associated factor. J Biol Chem 276:16399-16405.
51. Zhu N, Khoshnan A, Schneider R, Matsumoto M, Dennert G, Ware C, Lai MM. 1998. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 72:3691-3697.